Related Topics

Newsletter

LinkedIn
Vimeo
Facebook

Pipeline

Genea Biocells uses its proprietary stem cell technology platform for early discovery research to find diverse therapeutic interventions for neuromuscular diseases.

Drug Discovery Strategy
About neuromuscular diseases

Neuromuscular diseases are rare diseases affecting some part of the neuromuscular system such as:

Skeletal muscles

Peripheral motor nerves (in arms, legs, neck and face) or motor neurons in the spinal cord

Neuromuscular junctions, the connections between neurons and muscles

It is estimated that more than a million people in the United States are affected by some form of neuromuscular disease which are either acquired or genetic conditions. About 40 percent of patients are under age 18. Neuromuscular diseases are progressive in nature resulting in muscle weakness and fatigue. The onset of symptoms varies widely, as some diseases are present at birth, in childhood or in adults. Life expectancy also differs by disease and severity, from very short to normal length. Secondary effects of muscle deterioration such as heart and respiratory problems are often the cause of death.

Our Current Programs
Facioscapulohumeral Muscular Distrophy (FSHD) lead optimization stage
Satellite Cell Transplantation in vitro/in vivo optimization stage
Social media & sharing icons powered by UltimatelySocial